Roland Jurecic
Overview
Explore the profile of Roland Jurecic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barreras H, Copsel S, Bader C, Ding Y, Wolf D, Cash C, et al.
Transplant Cell Ther
. 2023 Feb;
29(5):341.e1-341.e9.
PMID: 36804930
The present studies examined experimental transplant outcomes using mobilized peripheral blood from mice and humans together with FoxP3+Treg cells. Donor mice were treated with filgrastim and / or plerixafor and...
2.
Jurecic R
Adv Exp Med Biol
. 2019 Sep;
1169:195-211.
PMID: 31487025
Hematopoietic stem cells (HSCs) maintain lifelong production of mature blood cells and regenerate the hematopoietic system after cytotoxic injury. Use of expanding cell surface marker panels and advanced functional analyses...
3.
Weston W, Jurecic V, Jurecic R
Haematologica
. 2017 Oct;
102(10):1627-1628.
PMID: 28965088
No abstract available.
4.
Weston W, Zayas J, Perez R, George J, Jurecic R
Sci Rep
. 2014 Jun;
4:5199.
PMID: 24903657
Populations of hematopoietic stem cells and progenitors are quite heterogeneous and consist of multiple cell subsets with distinct phenotypic and functional characteristics. Some of these subsets also appear to be...
5.
Weston W, Gupta V, Adkins R, Jurecic R
Immunol Res
. 2013 Nov;
57(1-3):34-43.
PMID: 24203441
Aplastic anemia (AA) is an immune-mediated and life-threatening form of acquired bone marrow failure (BMF), characterized by development and expansion of self-reactive T cells. These T cells cause continuous destruction...
6.
Jurecic R, Li L, Humphries R
Stem Cells Int
. 2012 Jun;
2012:580165.
PMID: 22685474
No abstract available.
7.
Urbieta M, Barao I, Jones M, Jurecic R, Panoskaltsis-Mortari A, Blazar B, et al.
Blood
. 2010 Mar;
115(23):4934-43.
PMID: 20200356
CD4(+)CD25(+)FoxP3(+) regulatory T cells (Tregs) possess the capacity to modulate both adaptive and innate immune responses. We hypothesized that Tregs could regulate hematopoiesis based on cytokine effector molecules they can...
8.
Kutlesa S, Zayas J, Valle A, Levy R, Jurecic R
Exp Hematol
. 2009 May;
37(8):909-23.
PMID: 19447159
Objective: Multipotent hematopoietic cell line EML can differentiate into myeloid, erythroid, megakaryocytic, and B-lymphoid lineages, but it remained unknown whether EML cells have T-cell developmental potential as well. The goal...
9.
Jing X, Infante J, Nachtman R, Jurecic R
Exp Hematol
. 2008 May;
36(9):1110-20.
PMID: 18495327
Objective: FLRF (Rnf41) gene was identified through screening of subtracted cDNA libraries form murine hematopoietic stem cells and progenitors. Subsequent work has revealed that FLRF acts as E3 ubiquitin ligase,...
10.
Zayas J, Spassov D, Nachtman R, Jurecic R
Stem Cells Dev
. 2008 May;
17(2):343-53.
PMID: 18447649
The c-kit receptor plays a vital role in self-renewal and differentiation of hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs). We have discovered that besides c-kit, the murine multipotent HSC/MPP-like...